About Protein disulfide-isomerase
Protein disulfide-isomerase (P4HB) is a protein
from Homo sapiens identified by UniProt accession
P07237, 508 residues long.
MolForge cross-references it against 0 known binders and
278 disease associations.
Target properties
| Protein name | Protein disulfide-isomerase |
| UniProt accession | P07237 |
| Gene | P4HB |
| Organism | Homo sapiens |
| Length | 508 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (278)
Diseases linked to this target (Open Targets).
- Cole-Carpenter syndrome · score 0.73
- osteogenesis imperfecta type 1 · score 0.37
- cutaneous melanoma · score 0.25
- lung adenocarcinoma · score 0.25
- breast adenocarcinoma · score 0.25
- genetic disorder · score 0.19
- squamous cell lung carcinoma · score 0.16
- endometrial cancer · score 0.14
- glioblastoma multiforme · score 0.12
- gastric adenocarcinoma · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P07237-F1 | alphafold | PREDICTED | 88.48 | — |
Amino-acid sequence (508 residues)
MLRRALLCLA VAALVRADAP EEEDHVLVLR KSNFAEALAA HKYLLVEFYA PWCGHCKALA PEYAKAAGKL KAEGSEIRLA KVDATEESDL AQQYGVRGYP TIKFFRNGDT ASPKEYTAGR EADDIVNWLK KRTGPAATTL PDGAAAESLV ESSEVAVIGF FKDVESDSAK QFLQAAEAID DIPFGITSNS DVFSKYQLDK DGVVLFKKFD EGRNNFEGEV TKENLLDFIK HNQLPLVIEF TEQTAPKIFG GEIKTHILLF LPKSVSDYDG KLSNFKTAAE SFKGKILFIF IDSDHTDNQR ILEFFGLKKE ECPAVRLITL EEEMTKYKPE SEELTAERIT EFCHRFLEGK IKPHLMSQEL PEDWDKQPVK VLVGKNFEDV AFDEKKNVFV EFYAPWCGHC KQLAPIWDKL GETYKDHENI VIAKMDSTAN EVEAVKVHSF PTLKFFPASA DRTVIDYNGE RTLDGFKKFL ESGGQDGAGD DDDLEDLEEA EEPDMEEDDD QKAVKDEL
Explore Protein disulfide-isomerase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets